Taliglucerase alfa (Elelyso, supplied by Pfizer) is funded to treat Gaucher disease.
On this page
Accessing funded taliglucerase alfa
The prescriber needs to download the the Special Authority form from the Schedule.
The prescriber then faxes the completed form to the Gaucher Panel for consideration. Do not use the standard Special Authority application process.
Contact the Panel
Gaucher Panel Co-ordinator
P O Box 10-254
Phone 04 460 4990
Fax 04 460 4995
Gaucher Panel members
- Dr Ian Hosford – Chair, Consultant Psychogeriatrician
- Dr Colin Chong – Radiologist
- Dr Timothy Hawkins – Haematologist
- Dr Callum Wilson – Metabolic Consultant
About Gaucher disease
Gaucher disease, a rare, inherited enzyme deficiency disorder which causes increased quantities of fats (lipids) to build up in the body, leading to a wide variety of symptoms.
There are about 20 New Zealanders affected by this disease.